Category

Vascular BioSciences recently awarded a NIH SBIR/STTR Phase I Commercialization Assistance Award to develop the CAR peptide as a therapeutic adjuvant. Goleta, CA., October 11, 2012 – Vascular BioSciences recently awarded a NIH SBIR/STTR Phase I Commercialization Assistance Award to de

Vascular BioSciences announces CEO David Mann will present “CAR Peptide, a Disease Selective Therapeutic Adjuvant For Targeted Drug Therapy” during the 7th Annual Therapeutic Peptide Symposium San Diego, CA., October 10, 2012 – Vascular BioSciences announces CEO David Mann will presen

Vascular BioSciences announced today that Dr. Kalju Kahn, PhD, has been named head of Medicinal Chemistry Goleta, Calif., July 3, 2012 – Vascular BioSciences announced today that Dr. Kalju Kahn, PhD, has been named head of Medicinal Chemistry. Dr. Kahn, an expert in computational chem

Vascular Biosciences announces publication of “Hemodynamic and Histologic Characterization of a Swine (Sus scrofa domestica) Model of Chronic Pulmonary Arterial Hypertension” Durnham, North Carolina, June 27, 2011 – Vascular BioSciences announces the publication of a scientific articl

Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Selected by Faculty of 1000 Goleta, Calif., June 24, 2011 – A recently published paper from Vascular BioSciences (VBS) in collaboration with Sanford-Burnham Medical Research Institute and the University of

VBS Pharmaceuticals announces publication of “Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Goleta, Calif., June 10, 2011 – VBS Pharmaceuticals, in collaboration with the Sanford-Burnham Medical Research Institute, and the University of South Alabama,

David Mann, CEO of Vascular BioSciences, Presents Opening Remarks at the Southern California Undergraduate Research Conference in Chemistry and Biochemistry (SCURC) Santa Barbara, Calif., April 24, 2011 – Opening speaker David Mann presented the following remarks at the SCURC at the U

Vascular BioSciences to Sponsor 2011 Southern California Undergraduate Research Conference in Chemistry and Biochemistry Santa Barbara, Calif., April 23, 2011 – Vascular BioSciences will be a major sponsor of the 2011 Southern California Undergraduate Research Conference in Chemistry

Vascular BioSciences, In Collaboration with the University of South Alabama, Awarded Exploration/Development R21 Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Cell-targeted Drug Delivery for the Treatment of Pulmonary Arterial Hypertension

Vascular BioSciences Awarded Qualifying Therapeutic Discovery Project Grant to Develop CAR Peptide as a Therapeutic Adjuvant San Diego, CA, November 9, 2010 – Vascular BioSciences was awarded a grant in the amount of $181,876 from the U.S. Government’s Qualifying Therapeutic Discovery